Abstract:Abstract Background Community-acquired pneumonia (CAP) is a common cause of morbidity and mortality in the elderly. Few studies compare the elderly (>65) and very elderly (≥85 years). We aimed to describe characteristics and patterns of care for very elderly patients hospitalized with CAP. Methods We conducted a retrospective cohort study using administrative data from 2010 to 2015 of about 660 US hospitals in the Premier database. Adults aged ≥65 years hospitalized with CAP, identified by either a principal ICD-9 code of pneumonia or a principal diagnosis of sepsis or respiratory failure coupled with a secondary code for pneumonia, were included. We compared demographics, insurance status, comorbidities, presentation characteristics and treatments among three age groups: 65–74, 75–84, and ≥ 85 years. Results The final sample included 488,382 patients aged ≥65 years, a third of whom were ≥85 years. Geriatricians cared for <1% of patients during hospitalization, regardless of patient age. Compared with those aged 65–74 years, the patients ≥85 were more likely to be female, of white race, have Medicare insurance, and a principal diagnosis of aspiration pneumonia (17.1% vs. 7%) (Table 1). The oldest group had higher rates of cardiac comorbidities, chronic kidney disease and dementia, but lower rates of diabetes, obesity, pulmonary disease, and smoking. On presentation, more of the very elderly had concomitant urinary tract infections. They were less likely to receive opiates and benzodiazepines, but more likely to receive foley catheters and antipsychotic medications. Antibiotics given in the first 2 days were similar across the groups. Fewer very elderly patients were admitted to the ICU or got ventilation compared with younger groups. More of the very elderly were discharged to hospice and fewer were discharged home. Compared with younger ages, the very elderly had similar lengths of stay but lower costs, and higher in-hospital mortality and 30-day readmission. Conclusion The very elderly represent a unique population with distinct clinical characteristics and outcomes from younger elderly patients. They have different co-morbidities and appear to receive less aggressive treatment with lower costs and higher mortality despite similar lengths of stay. Disclosures All authors: No reported disclosures.

Analysis of the Medication of Elderly Patients with Community-acquired Pneumonia in Our Hospital from 2010 to 2012

Causative Agent Distribution and Antibiotic Therapy Assessment among Adult Patients with Community Acquired Pneumonia in Chinese Urban Population.

Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward.

Study on the Clinical Pathway of Community Acquired Pneumonia

Analysis on the distribution and antibiotic resistance mechanism of healthy elderly intestinal Enterobacteriaceae bacteria

Clinical Effect of Antibiotic Therapy in The Treatment of Severe Pneumonia in Elderly Patients

Distribution and drug resistance of pathogens in elderly with community-acquired and hospital-acquired pneumonia

2206. Patterns of Care and Outcomes in Elderly Patients Hospitalized with Community-acquired Pneumonia in the United States

Clinical Analysis of Elderly Patients with Healthcare-Associated Pneumonia

Common Syndromes of Community Acquired Pneumonia and Analysis on Characteristics of Elderly Patients

Antibiotic Application in Elderly Inpatients:A Comparative Analysis

Application Analysis of Antibacterial Drugs in Inpatients with CAP

Potential for Cost-Savings in the Care of Hospitalized Low-Risk Community-Acquired Pneumonia Patients in China

Clinical features and prognostic factors of elderly patients with severe community-acquired pneumonia

Pathogenic bacterial profile and drug resistance analysis of community-acquired pneumonia in older outpatients with fever

Clinical evaluation on the empirical treatment of community acquired pneumonia

Effects of Age, Comorbidity and Adherence to Current Antimicrobial Guidelines on Mortality in Hospitalized Elderly Patients with Community-Acquired Pneumonia.

The Clinical Feature and Countermeasures of Hospital-Acquired Pneumonia in Non-Surgical Treatment Elderly Inpatients with Lung Cancer

Comparative analysis of pathogens in lower respiratory tract infections between elderly patients and young patients

Clinical Analysis of Etimicin Combined with Cefuroxime Axetil in the Treatment of Patients with Community-Acquired Pneumonia from 14 to 18 Years Old

Analysis of prognostic factors for hospitalized patients aged 95 years and over with community-acquired pneumonia